EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis

Shaofei Wang, Bingqing Bai, Qiming Huang, Yuanyuan Fang, Chenyu Zhang, Xinwen Chen, Jianglong Hong, Lei Jie, Hao Ding, Cui Hu, Hongye Li, Yang Li und 4 weitere

Endoscopy International Open · 01.10.2024 · 12 (10) · E1162-E1170

DOI: 10.1055/a-2409-1285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.10.2024. Verfasst von Shaofei Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Suzhou First People's Hospital, Suzhou, Anhui Province, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and study aims Pancreatic stenting effectively lowers the occurrence of post-ERCP pancreatitis (PEP) and reduces its severity. However, limited research has been conducted to determine the optimal timing for pancreatic stent placement. Our objective was to evaluate whether early pancreatic stent placement (EPSP) is more effective than late pancreatic stent placement (LPSP) in preventing PEP among patients with naive papilla. Patients and methods We conducted a retrospective cohort study that analyzed 590 patients with difficult biliary cannulation using the pancreatic guidewire technique, who were divided into EPSP and LPSP groups. In the EPSP group, a pancreatic stent was placed immediately before/after endoscopic retrograde cholangiography (ERC) or endoscopic sphincterotomy (EST). Conversely, in the LPSP group, a pancreatic stent was placed after partial/all completion of major endoscopic procedures.

Results

From November 2017 to May 2023, 385 patients were in the EPSP group and 205 in the LPSP group. EPSP was associated with a decreased PEP occurrence compared with LPSP (2.9% vs. 7.3%; P = 0.012). Similarly, hyperamylasemia was lower in the EPSP group (19.7% vs. 27.8%; P = 0.026). Furthermore, sensitivity analysis using multivariable analysis and propensity score–matched (PSM) analysis also validated these findings.

Conclusions

Early pancreatic stent placement reduced the incidence of PEP and hyperamylasemia compared with late pancreatic stent placement. Our findings favor pancreatic stenting immediately before/after ERC or EST.

Schlagwörter

Stichwörter der Autor:innen

ERC topicsPancreatobiliary (ERCP/PTCD)Statistics

Autor:innen und Institutionen

  • Department of Gastroenterology, Suzhou First People's Hospital, Suzhou, Anhui Province, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Qiao Mei

Zitieren

APA

Wang, S., Bai, B., Huang, Q., Fang, Y., Zhang, C., Chen, X., Hong, J., Jie, L., Ding, H., Hu, C., Li, H., Li, Y., Liu, X., Hong, R., Bao, J., & Mei, Q. (2024). Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis. Endoscopy International Open, 12(10), E1162-E1170. https://doi.org/10.1055/a-2409-1285

Vancouver

Wang S, Bai B, Huang Q, Fang Y, Zhang C, Chen X, et al. Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis. Endoscopy International Open. 2024;12(10):E1162-E1170. doi:10.1055/a-2409-1285

BibTeX
@article{Wang2024,
  author = {Wang, Shaofei and Bai, Bingqing and Huang, Qiming and Fang, Yuanyuan and Zhang, Chenyu and Chen, Xinwen and Hong, Jianglong and Jie, Lei and Ding, Hao and Hu, Cui and Li, Hongye and Li, Yang and Liu, Xiaochang and Hong, Rutao and Bao, Junjun and Mei, Qiao},
  title = {Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis},
  journal = {Endoscopy International Open},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {E1162--E1170},
  doi = {10.1055/a-2409-1285}
}
Kostenlos starten →